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Abstract
Streptomyces is the most important bacterial genus for bioactive compound 
production. These soil bacteria are characterized by a complex differentiation cycle. 
Streptomyces is extremely important in biotechnology, producing approximately 
two thirds of all antibiotics, as well as many compounds of medical and agricultural 
interest. Drug discovery from streptomycetes became challenging once the most 
common compounds were discovered, and the system was basically abandoned by 
industry. Simultaneously, antibiotic resistance is increasing dramatically, and new 
antibiotics are required. Screening from nature is being resumed (exploring new 
environments, looking for elicitors, metagenome, etc.). Secondary metabolism is 
conditioned by differentiation; although the relationship between both has long 
remained elusive, differentiation as a trigger for antibiotic production remains 
basically unexplored. Most cultures used in screening campaigns for new bioactive 
molecules have been performed empirically, and workflow was extremely produc-
tive during the so-called golden age of antibiotics; however, currently there is a 
bottleneck. Streptomyces is still the most important natural source of antibiotics, and 
it also harbors many cryptic secondary metabolite pathways not expressed under 
laboratory conditions. In this chapter, we review strategies based on differentiation, 
one of the keys improving secondary metabolite production and activating cryptic 
pathways to face the challenges of drug discovery.
Keywords: Streptomyces, screening, antibiotics, secondary metabolism, 
differentiation, elicitors, morphology, liquid cultures
1. Introduction
1.1 Streptomyces development
1.1.1 Solid cultures
The complex Streptomyces life cycle on solid-grown cultures is made up of differ-
ent phases.
Microorganisms on soils are exposed to different stress factors: chemical, 
physical and/or biological. Of these variable conditions, sometimes nutrients can 
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be limited, preventing growth [1]. A good survival strategy of some bacteria and 
fungi is the latency stage of spores. Under this stage, cells stop growing and their 
metabolism is mainly inactive [2]. Spores are very resistant to stress conditions. 
In Streptomycetes, they are formed by thick hydrophobic covers that preserve 
genetic information during unfavorable conditions. Spores are dispersed by wind, 
water or insects and remain in latency until germination in favorable situations 
[3]. Besides the thickness of the cell wall, their resistance to extreme temperatures 
and other physicochemical factors is because of their low water content [4]. In this 
dehydrated environment, molecules have inactive conformations (denaturalized 
proteins, etc.) that are stabilized and protected by the sugar trehalose [2]. From 
this null or limited metabolism, spores are able to germinate, as the macromol-
ecules needed have already been synthesized before the latency stage [2]. For 
germination, optimal hydration conditions are required. However, it can be faster 
and more successful in the presence of nutrients and specific stimuli. Spores also 
need enough levels of intracellular trehalose [5], and polyphosphates [6] that allow 
metabolic activity to commence before cells are able to detect and assimilate an 
external source of energy [2].
Despite the fact that germination is a very important stage in the Streptomyces life 
cycle, it has remained largely unstudied, because it is not an industrially important 
stage. When environmental conditions are prosperous, spores on soils/laboratory 
conditions (petri plates with solid culture medium) germinate. Germination of 
Streptomyces spores is a sequential process, divided into at least four stages: darken-
ing, swelling, emission of the germination tube [7] and reduced swelling [8].
Darkening is the stage in which spores allow the entry of water into the cell 
losing their impermeability and heat resistance. After a few minutes, spores change 
their optical characteristics and the cells are able to reactive their metabolism. 
Darkwelling requires bivalent cations such as Ca+2, Mg+2, Mn+2, Zn+2 and Fe+2 as 
well as energy reserves of the spore [7, 9, 10]. Degradation of the cover leads to the 
reactivation of the cell wall hydrolases. These enzymes, like Rpf (Resuscitation-
promoting factors), are involved in cell wall degradation, facilitating peptidoglycan 
remodeling by hydrolyzing glycosylic bonds B-1,4 between cell wall components, 
N-acetylglucosamine and N-acetylmuramic acid, which in turn, allow the access to 
external nutrients [2].
Swelling is the stage in which spores increase its volume due to the entrance of 
water. This increases the levels of glucose, as a result of trehalose hydrolysis [11]. This 
seems to be an essential step in germination since only when trehalose concentra-
tions decrease and proteins able to recover their functional conformations [12, 13]. 
Ribosomes are inactive inside the spores [14, 15]. However, only few minutes after 
germination starts (30–60 min), they are fully functional and new proteins can be 
translated [6]. During this stage, spores are metabolically active and are able to use 
trehalose as main energy source [11].
Emission of the germination tube: This stage begins at the same time as the first 
DNA replication, when spores are able to detect external sources of nutrients and 
adjust their metabolic pathways as a result [2]. The accurate point from which the 
germination tube is emitted is indicated by the accumulation of the protein, SsgA 
[3]. SsgA is not essential for germination; nevertheless, its absence significantly 
reduces the number of germ tubes in each spore, and its overexpression has the 
opposite effect [3].
Reduced swelling: Once the germ tube emerges, the spore starts to gradu-
ally reduce its swelling. This stage depends on the quantity of peptidoglycan 
cross-link that involves a carboxypeptidase (which corresponds to the SCO4439 
gene in the Streptomyces coelicolor genome www.strepdb.com). A deletion of this 
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carboxypeptidase causes spores to continue swelling until 5 μm diameter (2.5 
times more than the wild-type strain), after the emission of the germ tube [8]. The 
existence of this stage demonstrates that the regulation of water entering into the 
spores is complex and highly regulated.
During germination, several important morphological changes occur, including 
the degradation of the spore cover, which is mainly formed of peptidoglycan, and 
causing a huge increase of metabolic activity [2]. On the other hand, shortly after 
the emission of the germ tube, the expression of the protein DivIVA starts [6]. This 
protein plays a critical function in the vegetative growth and is located at the apex 
of the hyphae [16–18]. After germination, genes involved in cell division (like ftsZ) 
and proteins involved in cellular growth (like FilP) are expressed [2]. The expres-
sion of these genes is considered as the final of the germination phase [2, 6].
Curiously, during germination, three different secondary metabolites are 
produced: albaflavenone (a terpenoid) with an antibacterial effect against Bacillus 
subtilis, giving an important advantage in competitive environments, and two 
polyketides (germicidin A and chancone) with a germination inhibitory effect. 
These compounds are de novo generated during germination and are good examples 
of compounds produced during vegetative growth [19].
After germination, the Streptomyces mycelium starts to grow apically (regulated 
by divIVA gene) as a very transitory, multinucleated stage called first mycelium 
(MI), which is multinucleated [20]. This is a very transitory stage in which dead 
and living segments alternate in the same hyphae [21]. There are two kinds of 
septa separating segments during the MI stage: one of them is composed of a cell 
membrane and cell wall (with peptidoglycan) and the other, recently discovered, is 
a 1-μm spacing cross-membrane-based septa, without peptidoglycan [20]. FtsZ par-
ticipates in this septation, but it is not essential, as cross-membranes were observed 
in the FtsZ null mutant. Later, the dead segments are completely disintegrated 
and living segments continue apical growth. In this phase, the growth is especially 
branched [18].
After this early stage of branching growth, there is a morphological differen-
tiation into a second mycelium (MII), a sort of multinucleated mycelium with 
sporadic and apparently randomly positioned septa (formed of cell membrane and 
cell wall), which is the secondary metabolite producer [22]. This mycelium has two 
different populations: one of which remains as a branching mycelium growing on 
surfaces and is called substrate mycelium and the other develops hydrophobic cov-
ers and starts to grow into the air without branching (aerial mycelium) [18]. This 
is known as the “sky-pathway,” which regulates the expression of genes encoding 
proteins forming hydrophobic proteins (rodlins, chaplins and ramS) that cover the 
aerial hyphae. Some of the so-called “bald” (bld) mutants among others (defective 
in aerial growth) regulate the activation of this pathway [23]. At the end of the 
cycle, aerial hyphae undergo extensive synchronous septation (cell division) to cre-
ate up to 100 uninucleoid compartments, which finally differentiate to create chains 
of spores [24]. At the end of the cycle, the “white” (whi) genes are activated (whose 
mutants are defective in the formation of mature gray spores on the fluffy aerial 
mycelium) and the hyphae septate and sporulate [25].
1.1.2 Liquid cultures
Streptomyces differentiation in liquid cultures has hardly been studied, mainly 
due to the fact that most strains do not sporulate under these conditions. However, 
the fact that Streptomyces venezuelae is capable of sporulation in liquid cultures has 
made it a new study model in recent years [26].
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The applications of novel methodologies (confocal microscopy, proteomics, 
transcriptomics) to the study of Streptomyces biology have extended the knowledge 
regarding the development during the phases preceding sporulation in liquid 
cultures [27–31].
In these conditions, in most Streptomyces strains, aerial mycelium formation 
and sporulation are blocked [28]; so, there is no hydrophobic cover formation, or 
sporulation, but there is a first exponential growth phase corresponding to the 
compartmentalized MI morphology, and then there is a growth arrest phase cor-
responding to programmed cell death (PCD). After that, the hyphae, which remain 
alive, continue growing in a second exponential growth phase in which the mor-
phology of the hyphae becomes MII multinucleated mycelium, which corresponds 
to the antibiotic production [27, 30].
1.2 Correlation between Streptomyces life cycle and antibiotic production
Most industrial processes for secondary metabolite production are performed 
in liquid (flasks or bioreactors). This fact makes the knowledge of the Streptomyces 
behavior essential in these conditions. The optimization of Streptomyces liquid 
cultures has been empiric for decades; however, the end of the so-called “golden age 
of antibiotics,” which meant fewer and fewer compound discoveries or the advances 
in genome sequences revealing the existence of cryptic biosynthetic pathways that 
are not expressed under laboratory conditions, calls the attention of the scientific 
community.
Work on Streptomyces differentiation in liquid cultures has largely focused on the 
analysis of mycelial macroscopic morphology (pellets/clumps formation), media 
composition and bioreactor design [31]. The differentiation of the hyphae during 
the life cycle is essential for secondary metabolism [30]; however, there is still 
some controversy over which is the best morphology for production. Some authors 
affirm that pellets are better for production, while others report about clumps or 
even disaggregated growth. Hence, these conditions seem to be strain dependent. 
For instance, in Streptomyces olidensis (retamycin) [32], Streptomyces tendae (nik-
komycins) [33], Streptomyces lividans (hybrid antibiotics) [34] and Streptomyces 
coelicolor (Undecylprodigiosin, Actinorhodin) [30], pellet formation is essential for 
good production. However, in Streptomyces noursei (nystatin) [35] and Streptomyces 
fradiae (tylosin) [36], formation of pellets leads to worse antibiotic production than 
disaggregated growth. The lack of a reliable developmental model in streptomy-
cetes liquid cultures has hindered the precise identification of reliable phenotypes 
for use in the analysis and optimization of industrial fermentations. It has been 
demonstrated that antibiotics are produced by the substrate mycelium at the end 
of the proliferation phase, i.e., second mycelium morphology (after PCD process) 
[27, 30, 37]. However, despite the fact that there is a distinctive mycelium producing 
antibiotics (MII) [27, 30] (hence there is not secondary metabolite production until 
the differentiation of MII), antibiotic production has additional regulations, and 
each Streptomyces strain does not display its entire potential secondary metabolism 
at a specific developmental condition.
1.3 Screening for new bioactive compounds and drug discovery approaches
Most antibiotics and other bioactive compounds (antitumorals, immunosup-
pressors, etc.) were discovered from actinomycetes, but this source of drugs became 
challenging once the most common compounds were discovered. New antibiotic 
scaffolds are required, and resuming screening from nature is mandatory.
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During the past 30 years, only two new classes of antibiotics have been brought 
to the clinic for treatment systemic infections [38]. At the same time, microbial 
resistance to existing antibiotics has increased dramatically, rendering some micro-
bial infections that are extremely hard to treat. The current scenario looks gloomy, 
and there is a concrete risk of humanity returning to the pre-antibiotic era, with 
a high mortality from routine surgical or chemotherapeutic procedures because 
of infections by antibiotic-resistant pathogens. There is a general consensus that 
new antibiotics are urgently required and are the best chance in the fight against 
resistance.
Only a fraction of secondary metabolite pathways is active in actinomycete labo-
ratory cultures, and there are a large number of strains whose potential to produce 
bioactive compounds remains unexplored [39]. When whole genome sequencing 
became available at the start of the twenty-first century, the existence of many 
silent or cryptic biosynthetic gene clusters in actinomycetes was revealed, which 
may encode antibiotic-like substances but are not, or only poorly, expressed under 
laboratory growth conditions. Each Streptomyces strain harbors 20–50 biosynthetic 
pathways for natural products, for which only some products have been identified 
[39]. The big challenge is to find ways to activate these pathways so as to allow 
screening for new secondary metabolites from nature to resume.
2. Strategies in drug discovery
Once the most common antibiotics and bioactive compounds were discovered, 
drug discovery has become more challenging, and industry had mostly discontin-
ued the search for new drugs, with Streptomyces as the source. Nevertheless, the 
urgent necessity of new antibiotics in the clinic has caused screening from nature to 
be resumed [39]. New environments are being explored and some new actinomy-
cete strains have been discovered [40]; the potential of the marine environment has 
been highly explored during last decade, as well as some, a priori hostile soils, such 
as high mountains, deserts or icy places. The scientific community is also paying 
more attention to symbiotic relationships.
Thinking of natural conditions of growth is another important point of view. 
Laboratory/industrial conditions in which microorganisms are typically grown 
are very different conditions from nature, which imply the dormancy of most of 
the genetic pathways involved in antibiotic production, since these substances are 
related to stress conditions or defense against niche competitors. Furthermore, it is 
necessary to take into account that the majority of environmental bacteria are not 
easily culturable or are even nonculturable in laboratory conditions. This broad 
view is now possible, thanks to the access to the metagenome in different environ-
ments [41].
Another current strategy is to look for elicitors. Elicitors are small molecules, 
which are able to induce Streptomyces differentiation as well as trigger cryptic antibi-
otic pathways.
Additionally, secondary metabolism is conditioned by differentiation, so it is 
another aspect that requires special attention. As mentioned above, the life cycle 
stages and the mycelium morphology are keys for antibiotic production.
At present, different complementary strategies are being developed to improve 
secondary metabolite production and active cryptic biosynthetic gene clusters. 
One way to classify them is by unselective and selective methods [42], considering 
unselective methods are used in the improvement of screening of new activities and 
selective methods are used in the improvement of production of known molecules.
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2.1 Methods for searching for new bacteria/compounds
2.1.1 Exploring new environments
The actinomycetes are widely distributed in the environment; they were discov-
ered at the end of the nineteenth century as a group of soil-living microorganisms. 
However, their importance started in 1943 with the discovery of streptomycin, the 
first effective treatment against tuberculosis by the most important actinomycetes 
genus, Streptomyces. Researchers have isolated different Streptomyces as soil inhabit-
ants during decades as the most important source of antibiotics and bioactive 
compounds in nature. Clavulanic acid (Streptomyces clavuligerus [43]), neomycin (S. 
marinensis [44]), chloramphenicol (Streptomyces venezuelae [45]), the insecticide 
avermectin (Streptomyces avermitilis [46]), the immunosuppressant tacrolimus 
(Streptomyces tsukubaensis [47]), kanamycin (Streptomyces kanamyceticus [48]) and 
potent antitumoral platenolides (Streptomyces platensis [49]) are only few examples 
of the 12,400 bioactive compounds produced by the genus Streptomyces that society 
is routinely using in the clinic or agriculture. The rest of the phylum produces 3600 
bioactive compounds (being 3400 antibiotics) [50]. Until the 1980s, new bioactive 
compounds were discovered relatively easily; however, since 1985, only three new 
compounds have been discovered, with the last one, platensimycin (S. platensis 
[40]), in 2006.
Once the most common compounds are discovered and producer strains are 
isolated, one of the strategies for founding new activities is the exploration of 
new environments, under-exploited habitats, generally difficult to access. Marine 
environment are an important niche of new species of Streptomyces [51]. Besides 
marine actinomycetes, they have been isolated from Himalaya Mountains [52], 
several islands [53], Atacama Desert [54], Antarctica [55] and several extremophile 
habitats [56–58].
Promising results and new species are being discovered from these unexplored 
areas, in combination with next-generation genome sequencing, metagenomics and 
new ways of bacterial culture [59], being one of the most important approaches in 
the new age of bioactive compound research.
2.1.2 Symbiosis relationships
As mentioned above, Streptomyces are ubiquitous in soils. However, it has been 
discovered that they are not only free-living soil bacteria but many have also 
evolved to live in symbiosis with plants, fungi and animals [60]. Their secondary 
metabolism is a consequence of these complex interactions [60].
There are many and very diverse symbiotic relationships, which involve 
Streptomyces. One of the first discovered is its relationship with plant roots provid-
ing a natural defense against fungal infections [61]; it is very common to find 
bacteria of the Streptomyces genus in the rhizosphere. This fact raises the possibility, 
currently discussed, about its use as biofertilizers in crops [62, 63]. Furthermore, 
genome mining is now allowing us to know on one hand which genes are involved 
in this interaction and on the other hand the discovery of potential novel molecules 
produced only in these conditions [64].
Other important interactions of Streptomyces genera take place between bacteria 
and insects. For instance, in the case of Beewolf digger wasps, Streptomyces provides 
protection against pathogens to the larval cocoon producing a mixture of nine 
antibiotic compounds [65, 66].
In Streptomyces isolates from colonies of the South African termite Macrotermes 
natalensis, a number of interesting novel compounds including natalamycin A 
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[67] and the potent antitumor geldanamycin [67] have been discovered. Another 
Streptomyces isolate from the same termite produces a novel cyclic analogue of 
dentigerumycin [68], the antifungal from the fungus-growing ant system. Finally, 
a series of glycosylated isoflavonoid compounds, including termisoflavone A [69], 
were recovered from a third Streptomyces isolate.
In 2012, 30 Streptomyces strains were isolated from a different South African 
fungus-growing termite, Microtermes sp., and two novel polyketides, microter-
molides A and B [69], were identified.
Two Streptomyces strains, isolated from Dendroctonus frontalis beetles, inhibit the 
antagonistic Ophiostoma fungus, but not the mutualistic fungus Entomocorticium, 
suggesting a defensive role that supports the beetle-fungus mutualism. The mol-
ecules responsible for this selective antifungal activity are the polyketide mycangi-
mycin [70] and the polycyclic tetramate macrolactams, frontalamides A and B 
[71, 72].
Other important symbiotic relationship takes place between ants and 
Streptomyces. In recent years, new strains and compounds have been isolated from 
ant head, legs and nests [73–76].
2.1.3 Nonculturable microorganisms
Since the beginning of microbiology, it was known that many microorgan-
isms do not grow under laboratory conditions and we cannot cultivate them. 
The new techniques of massive sequencing have revealed the existence of a huge 
amount of nonculturable microorganisms. Nonculturable microorganisms are, 
in fact, a majority, and they represent an important challenge in the screening 
for new secondary metabolites. Next generation sequencing (NGS) has revealed 
the big pharmacological potential of uncultured bacteria; hence, approaches 
to improve cultivation-based methods, such as isolation chip (iChip), which 
is a method of culturing bacteria within its soil environment, or co-cultures, 
culturing actinomycetes with other bacteria (generally species with which they 
naturally coexist), are being used successfully [70–72]. The combination of 
iChip and unexplored ecosystems or symbiotic relationships, mentioned above, 
is promising as well.
2.2 Methods for screening improvement in a known microorganism (unselective)
Unselective methods include classical strategies for improving the production 
of a certain compound by modifying the growth of the Streptomyces strain. This 
strategy used to be empiric.
2.2.1 Changing media components
Streptomyces grow well in rich culture mediums; nevertheless, antibiotic produc-
tion often needs some specific nutrients. Sometimes defined medium can be better 
for determined compounds. Optimization of nutritional requirements has been one 
of the most useful changes for secondary metabolite activities [73–76].
2.2.2 Inducing stress response
Stressful situations are one of the reasons why microorganisms start to produce 
and export bioactive compounds. For this reason, the induction of cultures with 
several treatments of stress is one of the improvement strategies for synthesis of 
secondary metabolite compounds in bacteria. Heat and ethanol shock treatments, 
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high salt conditions, increased hydrostatic pressure, acidic pH shock or feed limita-
tions are some examples of this classical strategy (reviewed in [77]).
2.2.3 Random mutagenesis
There are different random mutagenesis methods used in Streptomyces: chemical 
mutagenesis, in which are used (e.g., by N-methyl-N′-nitro-N-nitrosoguanidine 
(MNNG), ethyl methanesulfonate (EMS), or nitrous acid (NA)) and physical 
mutagenesis (e.g., by ultraviolet (UV) light or X-rays)) that remain being robust 
methods to generate very high-producing strains [78–80].
On the other hand, there is transposon mutagenesis, a powerful tool for random 
mutagenesis of bacterial genomes and insertion of foreign DNA. A plasmid con-
taining the enzyme transposase and the transposon (small fragment of DNA with 
transposase target regions) is extracted and inserted randomly into the host chro-
mosome. Transposition creates single mutations that can be identified and mapped 
by plasmid rescue and DNA sequencing, generating a direct link between the higher 
yield (phenotype) and the transposon insertion (genotype) [81, 82].
2.2.4 Ribosomal engineering
The fact that some antibiotic resistances trigger some cryptic pathways of sec-
ondary metabolites has been recently used as another strategy in the search for new 
compounds.
It has been demonstrated that this occurs in strains affected by antibiotics, 
which target a ribosomal protein (for instance, streptomycin, paromomycin and 
gentamicin [42]), so the effects of the mutations at this level have had very good 
results, for example, in Streptomyces coelicolor, for improving secondary metabolite 
production [83]. The mechanism of this strategy is still unknown, but it has been 
proved that there is activation of the positive regulators like actII-orf4 gene at least 
in S. coelicolor [42]. Through this approach, the antibacterial piperidamycins family 
compounds have been discovered [84].
2.2.5 Elicitors
Elicitors are small diffusible molecules, which are being used as signals for 
improving secondary metabolite production or even activating cryptic antibiotic 
pathways [85].
Elicitors are also present in Streptomyces natural environments; hence one of 
the strategies for stimulating bioactive compound production is the co-culture of 
different bacteria [85, 86]. Co-cultures usually include species that have symbiotic 
relationships with Streptomyces in nature [87, 88] or pathogenic partners to activate 
the production of antimicrobial compounds against them [71, 89, 90].
Other kinds of elicitors are also useful, for instance, fungal elicitors (a complex 
mix of fungal cell walls and filtered fungi cultures) can positively affect the produc-
tion of natamycin [91]; small molecules, such as GlcNac or phosphate, can activate 
differentiation and antibiotic production in S. coelicolor through the activation of 
actII-ORF4/redZ genes in some conditions [92].
At the end of the 1980s, the discovery of new compounds reached a bottle-
neck, and screening processes often led to the rediscovery of compounds already 
known. To avoid rediscovery, Pimentel-Elardo et al. [93] developed a workflow 
based on the use of chemical elicitors combined with activity-independent 
screening [93]. Activity-independent screening is based on the low-abundant 
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compounds found in biological samples. The use of elicitors increases the pro-
duction of these low-abundant compounds, distinguishing them from the most 
abundant ones. The elicitor “CI-ARC” has been identified as being responsible for 
triggering several cryptic biosynthetic genes [93].
2.2.6 Differentiation strategies based on morphology
2.2.6.1 Streptomyces behavior in liquid cultures
Large-scale antibiotic production is mostly performed in liquid cultures. 
Macroscopic morphology of the mycelium (pellets and clumps) correlates with 
the production of secondary metabolites [30]. The genes controlling mycelium 
aggregation have been characterized in the S. coelicolor mat gene cluster [94], and 
the cslA, glxA and dtpA genes [95–97] are responsible for pellet formation. This 
knowledge can be used for controlling and improving morphology in industrial 
fermentations.
Since spores are inoculated in liquid medium, there is an aggregation trend [98]. 
Germlings determine the macroscopic morphology (pellets and clumps) of the cul-
ture, which involves the highly conserved genes matA, matB [94, 98] and the cslA/glxA 
operon [98].
In liquid cultures, there are some strains able to sporulate [99], but even those 
which aren’t able to sporulate in flasks can sporulate in bioreactors, beacuse of the 
stess conditions inside the fermenter, such as lack of oxygen, strong agitation, etc. 
[100]. When Streptomyces bacteria sporulate, all the metabolic efforts are focused 
on that, which means that the secondary metabolism stops by. Therefore, one 
of the main things for taking into account during a screening for new secondary 
metabolites is to avoid sporulation in the industrial fermentations. Hence, it is very 
important to look out the cultures for keeping secondary metabolism as much as 
possible [100].
Morphology in liquid cultures can be monitored by several tools. Laser 
diffraction has been used to measure pellet size, an improvement over image 
analysis, which is trickier and requires more time [101], and a technique based 
on flow cytometry has been used to establish the pellet size distribution of a 
culture population [102, 103]. Recently, a useful algorithm has been developed 
as a plugin for the open-source software ImageJ to characterize the morphology 
of submerged growing cells [104]. On the other hand, mathematical models have 
been performed to predict the behavior of Streptomyces liquid cultures based on 
pellet/clump morphology [105, 106].
Furthermore, it has been reported that the oxygen transfer rate (OTR) and 
oxygen uptake rate (OUR) are crucial for the development and production in liquid 
cultures [100]. Controlling these rates, which directly affects morphology, was 
described as being crucial for scaling up production to industrial conditions [107]. 
Biophysical parameters, including pH, viscosity, agitation, dissolved oxygen levels 
and surface tension, directly affect mycelium morphology. The optimization of 
these factors is another factor to consider [31].
2.2.6.2 Programmed cell death and MII differentiation
As mentioned in the introduction of this chapter, programmed cell death 
(PCD) is a key event, triggering the differentiation of antibiotic producer myce-
lium (MII) in liquid and solid cultures [30]. However, the specific signals derived 
from cell death are not yet known. The N-acetylglucosamine resulting from 
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peptidoglycan dismantling accelerates the development and antibiotic production 
[108, 109] and might be one of the signals released during PCD. A simple meth-
odology based on fluorimetric measures was designed to quantify PCD in liquid 
cultures [37], allowing prediction of the efficiency of antibiotic production based 
on the level of PCD.
PCD and MII differentiation can be modulated by modifying culture condi-
tions and morphology. Modifying developmental conditions to enhance PCD and 
MII differentiation leads to the improvement of secondary metabolite produc-
tion. This approach was recently applied in a study combining the heterologous 
expression of plant flavonoids in Streptomyces albus with a strategy to enhance 
PCD and MII differentiation [110]. The same strategy was successful at improving 
mTGase production from Streptomyces mobaraensis [111]. Therefore, PCD and MII 
differentiation were demonstrated to be crucial for the streamlining of secondary 
metabolite production in bioreactors [100].
2.3 Methods for production improvement in a known compound (selective)
Selective methods with a specific target include regulatory engineering, heter-
ologous expression, genome mining and combinatorial biosynthesis.
2.3.1 Regulatory engineering
Each active compound, for example, antibiotic or antitumor, etc., has several 
molecules synthesized first in the pathway, and sometimes these molecules are a 
limited source for the compound of interest. In this sense, one strategy widely used 
is the addition of these precursors, previously synthetized from an external source. 
In the same way, it is possible to enhance the production of a specific compound 
through the overexpression of its positive regulators. Inversely, knocking out the 
suppressors (negative regulation) of the gene of interest has also had good results 
increasing the final compound production [112, 113].
2.3.2 Heterologous expression
In microbiology, this molecular genetic technique is based on the expression of a 
gene or a group of genes (gene cluster) in a host microorganism that does not have 
this particular gene or gene cluster in its own genome. This procedure, performed 
by recombinant DNA technology, is very useful when hosts are bacteria with 
simple developmental cycles, such as E. coli or Bacillus [114]. However, in the case 
of Streptomyces, due to its complex pathways to produce antibiotics, heterologous 
expression usually works only among Streptomyces strains [115, 116], not solving the 
problem of its tricky growth.
Nevertheless, good results have been achieved in activating cryptic metabolites, 
for example, by using the widely conserved Streptomyces coelicolor pleiotropic 
regulator AfsQ, which activates the production of new compounds in several 
streptomycetes [117]. Despite the fact that heterologous expression in Streptomyces 
is a challenge, this technique continues to be improved [118].
2.3.3 Genome mining
Genome mining is defined as the obtaining of information about an organ-
ism, based on genome analysis. In the postgenomic era, the combination of easier 
genome sequencing and bioinformatics analyses allows researchers to uncover the 
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biosynthetic potential of the microorganisms, i.e., the gene clusters for producing 
secondary metabolites into actinomycetes strains that are in the genome, but silent. 
Genome mining is nowadays one of the more powerful tools in the screening for 
new antibiotics [119–122].
2.3.4 Combinatorial biosynthesis
Combinatorial biosynthesis can be defined as the application to modify biosyn-
thetic pathways to natural products to produce new and altered structures using 
nature’s biosynthetic machinery [123]. The chemical modification of existing 
chemical scaffolds is challenging and sometimes provides only a temporary solu-
tion against resistant organisms [124]. Combinatorial biosynthesis has been largely 
developed over the last 20 years, and it has been enhanced, thanks to genome 
mining and synthetic biology [125–127].
3. Conclusions
Humanity faces the great challenge of fighting antibiotic resistance, which is 
growing at a faster rate than our capacity to find new antimicrobials and new strate-
gies to solve this problem.
The Streptomyces genus is still a huge source of natural bioactive compounds, 
but we need to elaborate new multidisciplinary strategies to avoid rediscovering the 
same compounds. Therefore, we need to invest efforts into developing alternative 
strategies to resume screening from natural actinomycetes.
There is not a “magic” methodology to activate cryptic pathways and 
improve the discovery of new bioactive compounds, but multidisciplinary 
approaches combining the methodologies discussed in this chapter will play a 
key role in the improvement of screening for new bioactive compounds from 
streptomycetes.
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